SameerBansilalMD, MS, FACC
Cardiology • Bronx, NYNon-Invasive Cardiology, Preventive Cardiology
Attending Physician, James J. Peters Department of Veterans Affairs Medical Center
Dr. Bansilal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
130 W Kingsbride Rd
Bronx, NY 10468Phone+1 917-627-0702- Is this information wrong?
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2007 - 2011
New York-Presbyterian Brooklyn Methodist HospitalResidency, Internal Medicine, 2002 - 2005
Seth G.S. Medical CollegeClass of 2001
Certifications & Licensure
NY State Medical License 2005 - 2025
MA State Medical License 2012 - 2014
Publications & Presentations
PubMed
- 4 citationsModifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone.Rajiv Agarwal, Bertram Pitt, Peter Rossing, Stefan D Anker, Gerasimos Filippatos, Luis M Ruilope, Csaba P Kovesdy, Katherine Tuttle, Muthiah Vaduganathan, Christoph Wa...> ;JAMA Cardiology. 2023 Aug 1
- 10 citationsPatient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.Marc P Bonaca, KyungAh Im, Giulia Magnani, Sameer Bansilal, Mikael Dellborg, Robert F Storey, Deepak L Bhatt, P Gabriel Steg, Marc Cohen, Per Johanson, Eugene Braunwal...> ;European Heart Journal. 2022 Dec 21
- 3 citationsChange in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study.Raymond L. Benza, Athénaïs Boucly, Harrison W. Farber, Adaani E. Frost, Hossein Ardeschir Ghofrani, Marius M. Hoeper, Marc Lambelet, Claudia Rahner, Sameer Bansilal, S...> ;The Journal of Heart and Lung Transplantation. 2021 Oct 28
- Join now to see all
Authored Content
- Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients with Multivessel Coronary DiseaseJanuary 2018
Press Mentions
Bayer’s KERENDIA® (Finerenone) Receives Updated Label to Include Findings from Phase III FIGARO-DKD Cardiovascular Outcomes Study in Patients with Chronic Kidney Disease and Type 2 DiabetesSeptember 1st, 2022- Bayer’s KERENDIA® (Finerenone) Receives New Recommendations from American Diabetes Association for Improving Cardiovascular Outcomes and Managing Patients with Chronic Kidney Disease Associated with Type 2 DiabetesJune 28th, 2022
- Bayer Doles Out $1M of Its PHAB Awards to 7 Research ProjectsSeptember 13th, 2021
- Join now to see all
Professional Memberships
- Member
Other Languages
- Hindi, Marathi, Urdu
Hospital Affiliations
James J. Peters Veterans Affairs Medical CenterBronx, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
